Related Experiment Video
Updated: Jul 19, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Carotid artery stenting: where are we now?
1CardioVascular Center Frankfurt, Sankt Katharinen, Seckbacher Landstrasse 65, 60389 Frankfurt, Germany. kasja.rabe@gmx.de
Minerva Cardioangiologica
|October 5, 2006
Summary
Carotid artery stenting (CAS) is a viable treatment for ischemic stroke, especially for high-risk patients. Further trials are needed to confirm long-term outcomes and benefits in low-risk groups.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Cardiology
Background:
- Carotid artery disease is a significant risk factor for ischemic stroke.
- Carotid endarterectomy was the standard treatment for high-grade stenosis.
- Carotid artery stenting (CAS) has emerged as a promising alternative.
Purpose of the Study:
- To review the current evidence on carotid artery stenting (CAS).
- To compare CAS with carotid endarterectomy.
- To discuss the role of cerebral protection devices in CAS.
Main Methods:
- Review of randomized trials and clinical series.
- Analysis of outcomes in high-risk and low-risk patient groups.
- Evaluation of neurological events associated with CAS.
Main Results:
- CAS shows promising results, particularly for high-risk surgical patients.
- Cerebral protection devices appear to reduce neurological events during CAS.
- Further randomized trials are needed for low-risk patients and long-term data.
Conclusions:
- CAS is a valuable option for treating carotid artery stenosis, especially in high-risk individuals.
- Cerebral protection is recommended during CAS.
- Ongoing research will clarify the long-term efficacy and optimal patient selection for CAS.